Wright Medical Group N.V. Announces FDA Premarket Approval for AUGMENT® Injectable Bone Graft
June 13, 2018 06:00 ET
|
Wright Medical Group N.V.
Clinically Proven, Cost-Effective, Injectable Formulation of AUGMENT® Approved in U.S. for Ankle and/or Hindfoot Fusion Company Can Now Initiate Commercial Sale and Distribution in the U.S. Company...
BioElectronics Receives FDA Pre-Submission Approval for its Post-Operation Pain Market Clearance Application
May 29, 2018 11:48 ET
|
BioElectronics Corporation
FREDERICK, MD, May 29, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com reports that it has cancelled today’s scheduled US Food and Drug Administration meeting....
VESTEX® Active Barrier Healthcare Scrubs First-Ever to Receive FDA Designation as Class II Medical Device
May 23, 2018 08:00 ET
|
Vestagen Protective Technologies, Inc.,
Orlando, Fla., May 23, 2018 (GLOBE NEWSWIRE) -- Vestagen Protective Technologies, Inc., which develops and markets healthcare worker uniforms, scrubs, lab coats and other garments utilizing its...
IlluminOss Medical Granted FDA Marketing Clearance for the IlluminOss® Bone Stabilization System
January 09, 2018 09:00 ET
|
IlluminOss Medical
EAST PROVIDENCE, R.I., Jan. 09, 2018 (GLOBE NEWSWIRE) -- IlluminOss Medical, a privately held, commercial-stage medical device company focused on minimally invasive orthopedic fracture repair, today...
BioCorRx Selects Covance for Non-Clinical Studies, Announces the Addition of Dr. Bal S. Brar to its Drug Development Team, Plans Pre-IND Meeting with FDA
November 28, 2016 06:00 ET
|
BioCorRx
ANAHEIM, CA, Nov. 28, 2016 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTC PINK: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions,...
biotricity Receives an FDA 510(k) Clearance – Marks Major Milestone in Path to Commercialization
October 18, 2016 08:00 ET
|
biotricity
REDWOOD CITY, Calif., Oct. 18, 2016 (GLOBE NEWSWIRE) -- biotricity inc. (OTCQB:BTCY), a healthcare technology company dedicated to delivering innovative, medically relevant biometric remote...
Cohera Medical, Inc.® Receives FDA Approval to Begin Clinical Trials of its Sylys® Surgical Sealant in the U.S.
July 12, 2016 09:30 ET
|
Cohera Medical, Inc.
RALEIGH, N.C., July 12, 2016 (GLOBE NEWSWIRE) -- Cohera Medical, Inc., a leading innovator and developer of absorbable surgical adhesives and sealants, today announced that it has received...
Wright Medical Group, Inc. Announces FDA Approval for AUGMENT(R) Bone Graft
September 01, 2015 16:00 ET
|
Wright Medical Group N.V.
First Clinically Proven, Cost-Effective Alternative to Autograft for Ankle and/or Hindfoot Fusion Indications Company Can Now Initiate Commercial Sale and Distribution of AUGMENT® Bone Graft in the...
BioCorRx, Inc. CFO, Lourdes Felix discusses 10-K Filing for 2013
April 15, 2014 16:31 ET
|
BioCorRx
Los Angeles, April 15, 2014 (GLOBE NEWSWIRE) -- BioCorRx,
Inc. (BICX), a leader in addiction treatment programs,
announces its financial results for the 12 months ending December
31,...
Kelyniam Global Inc. Announces Second Quarter 2012 Revenues
October 15, 2012 09:29 ET
|
Kelyniam Global Inc.
Canton, CT, Oct. 15, 2012 (GLOBE NEWSWIRE) -- Second Quarter Results
Kelyniam Global Inc. (OTC: KLYG) For the quarter ending June
30th 2012 Kelyniam Global Inc. reported a loss of
$45,692...